Analyst Moves: MRK, SNDK, INTC - Presented by: The Aol. On Network

This morning, BMO downgraded shares of Merck (MRK) from outperform to market perform as certain drugs in the company's portfolio could begin to see increased competition. With the downgrade, BMO set a $51 price target.

Related Videos

Most Popular Videos

Latest Videos